TGFB1 and neoplasm: TGFβ is a pleotropic cytokine involved in normal physiological function, which may be why small molecule inhibitors targeting TGFβ-dependent signaling have shown a high propensity for associated toxicities in preclinical models, including cardiac toxicities and the development of neoplasms.23